Rational design and synthesis of flavonolactam derivatives as potent topo I inhibitors with antitumor activity

Xiaoyu Shi1, Yaoguang Huang1, Xupeng Yang1

  • 1School of Traditional Chinese Materia Medica, Shenyang Pharmaceutical University, Shenyang, 110016, People's Republic of China.

Insights

New flavonolactam derivatives show promise for colorectal cancer treatment. Compound NL-26 effectively inhibits topoisomerase I (Topo I), suppresses tumor growth in models, and warrants further investigation.

Area of Science:

  • Medicinal Chemistry
  • Oncology
  • Molecular Biology

Background:

  • Topoisomerase I (Topo I) is a key target for colorectal cancer (CRC) therapy.
  • Developing novel inhibitors with improved efficacy and pharmacokinetic profiles is crucial.

Purpose of the Study:

  • To design, synthesize, and evaluate novel flavonolactam derivatives as Topo I inhibitors for CRC.
  • To investigate the mechanism of action and in vivo efficacy of promising compounds.

Main Methods:

  • Synthesis of a series of flavonolactam derivatives.
  • In vitro evaluation of Topo I inhibitory activity and cell cycle arrest.
  • Apoptosis induction assays.
  • In vivo pharmacokinetic and antitumor efficacy studies in HCT116 xenograft models.

Main Results:

  • Compounds NL-26 and NL-28 demonstrated potent Topo I inhibition.
  • NL-26 exhibited strong Topo I inhibitory activity, comparable to camptothecin (CPT).
  • NL-26 showed favorable pharmacokinetics (AUC 1979.7 µgh/mL, t1/2 3.7 h) and significant antitumor efficacy (55.1% TGI) in vivo.

Conclusions:

  • NL-26 is identified as a promising lead compound for CRC therapy.
  • The flavonolactam scaffold is validated as a valuable template for developing novel Topo I inhibitors.

Related Concept Videos

Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These...
54
DNA Topoisomerases02:02

DNA Topoisomerases

Topoisomerases are enzymes that relax overwound DNA molecules during various cell processes, including DNA replication and transcription. These enzymes regulate positive and negative DNA supercoiling without changing the nucleotide sequence. DNA overwinding in a clockwise direction results in positively supercoiled DNA, whereas underwinding in a counterclockwise direction produces negatively supercoiled DNA.
Types and Mechanism of action
Topoisomerases are divided into two main types. ...
37.7K
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
83
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
54